Orioles pitcher Brian Matusz, like several million Americans, is allergic to peanuts. So much so that he had a bad reaction during spring training that required him to go to the emergency room.
An eight-year-old boy from Georgia named Wyatt Alford also has a peanut allergy. He read about Matusz’s incident and, when visiting Sarasota for an Orioles spring training game, sought Matusz out. Ballparks being what they are, he couldn’t connect with Matusz, but at the suggestion of Orioles’ staff he wrote to him. The story about it is in the Baltimore Sun today. Specifically, about what Matusz found when he opened the envelope from Alford:
Inside the envelope was a newspaper article detailing Matusz’s frightening allergic reaction to a dinner prepared in peanut oil March 9 that sent the 27-year-old left-hander to the emergency room.
Also included in the package was a portable shot of epinephrine that allergy sufferers carry in case of a reaction. Although similar in content to the ubiquitous EpiPen, the Auvi-Q inside Matusz’s envelope was instead square and flat like a thick credit card — easy for autographing — and included audio instructions for injecting it.
I’ve talked about how autographs are weird and I don’t always get the desire for having one, but with a connection like this one — and an autograph on something so special and personalized — all that goes out the window.
According to Jorge Castillo of the Washington Post, Nationals infielder Danny Espinosa declined to attend the team’s annual Winterfest because of his dissatisfaction with management following their trade for outfielder Adam Eaton.
A source told Castillo that Espinosa’s unhappiness stemmed from a belief that the acquisition would jeopardize his starting role in 2017. With Eaton in center field, Trea Turner will likely return to his post at shortstop, leaving Espinosa out in the cold — or, as the case may be, on the bench. The move shouldn’t come as a big surprise to Espinosa, however, as Nationals’ GM Mike Rizzo spoke to the possibility of trading the infielder or reassigning him to a utility role back in early November.
Offensively, the 29-year-old had a down year in 2016, slashing just .209/.306/.378 with 24 home runs in 601 PA. Defensively, he still profiles among the top shortstops in the National League, with eight DRS (Defensive Runs Saved) and 8.3 Def (Defensive Runs Above Average) in his seventh year with the club.
Espinosa will reach free agency after the 2017 season.
The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.
The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.
Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.
Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.